Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00467454
Status:
WITHDRAWN
Last Update Posted:
2011-12-14
First Post:
2007-04-27
Brief Title:
Naltrexone in the Treatment of Pyromania
Sponsor:
University of Minnesota
Organization:
University of Minnesota
Study Overview
Official Title:
A Double-Blind Placebo-Controlled Study of Naltrexone in Pyromania
Status:
WITHDRAWN
Status Verified Date:
2011-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Funding allocation to different clinical trials
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The proposed study will consist of 8 weeks of treatment with either naltrexone or placebo in 10 subjects with pyromania
Detailed Description:
The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in pyromania Ten subjects with DSM-IV pyromania will receive 8 weeks of naltrexone or placebo The hypothesis to be tested is that naltrexone will be effective in reducing the urges to set fires patients with pyromania The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None